Portfolio company
Readily
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops rapid molecular diagnostic tests for infectious diseases for healthcare providers and patients without access to laboratory infrastructure.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
StatDx
This company develops point-of-care molecular diagnostic systems for healthcare providers to identify infectious diseases and critical care conditions.
DiagonalBio
This company develops molecular diagnostic systems for rapid, point-of-care pathogen detection in human healthcare, veterinary, and agricultural markets.
Lucira Health
This company manufactures disposable molecular diagnostic kits for infectious diseases including COVID-19 and influenza for healthcare providers and consumers.
Cue Health
This company manufactures portable molecular diagnostic systems for at-home and clinical testing of infectious diseases for individuals and healthcare providers.
AccSys Diagnostics
This company develops portable point-of-care devices for testing infectious diseases such as HIV and Hepatitis for healthcare providers and mobile clinics.
Rapidemic
Rapidemic develops molecular point-of-care diagnostic tests for sexually transmitted infections, providing results for patients and clinicians without requiring laboratory infrastructure or external power.
DxLab
This company develops point-of-care molecular testing systems and rapid diagnostic tests for pathogens to serve healthcare providers and public health teams.
Nanopath
This company develops point-of-care molecular diagnostic tests and hardware for pelvic and gynecologic infections to provide rapid results for healthcare providers and their patients.
